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BACKGROUND AND LIMITATIONS OF THE CONVENTIONAL
IN VITRO METHODS TO ASSESS DIGESTIBILITY OF DIETARY
CARBOHYDRATES
Scientific evidence of human digestion of foods gathered during the last decades has strengthened
the relationship between digestibility and the possible effects of foods on human health (1). The
high complexity of the gastrointestinal (GI) environment and the lack of an easy direct access
to most of the parts of the GI tract (2) with the exception of the oral cavity, prevent the broad
implementation of in vivo animal, or human trials for assessing the digestion, absorption, and
metabolism of dietary food ingredients. Therefore, in vitro testing has a central place in the current
investigations of food’s digestive fate.
Non- or slowly digestible carbohydrates may have appealing properties that are associated with
a series of beneficial physiological effects, such as low-calorie (important in preventing obesity),
low-glycemic (helpful inmanaging diabetes and cardiovascular disease), and low-digestible (helpful
in reducing the intestinal transit time and in positively modulating the gut microbiota composition
and activity). These beneficial effects have sparked the interest, from both academic and industry
perspectives, in carbohydrates showing resistance to digestion (or slow digestibility) and absorption
in the small intestine and thus being available in the large intestine as substrates for fermentation
by gut microbiota.
Since Southgate published, in the late 1960s, two methods for measuring available (3)
and unavailable (4) carbohydrates in foods by hydrolyzing starch with amyloglucosidase and
pullulanase of fungal origin, a plethora of models ensued with the common rationale of using
amylolytic enzymes that, in some cases, may be combined with a microbial invertase (5).
Remarkably, the substrate specificity, hydrolytic mechanism and influence in physiologic responses
of amylolytic enzymes from fungal or bacterial sources commonly used in in vitro starch digestion
assays has been demonstrated to be noticeably different from their equivalent in mammals (6, 7).
The current state-of-the-art reveals that human gastrointestinal digestion of dietary
carbohydrates is a multistage process, involving up to six different carbohydrases produced by
three different organs (Table 1). The main function of the oral phase is the conversion of food into
a homogenous mass during mastication, whilst the starchy carbohydrates undergo a very limited
salivary α-amylolysis. The main site for carbohydrate digestion is the small intestine, where the
chyme is mixed with α-amylase containing secretions of the pancreas. In addition, the key role
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played by the mucosal disaccharidases embedded in the small
intestinal brush border membrane vesicles that are responsible
for the final stage of luminal digestion prior to absorption needs
to be recognized (11, 12) (Table 1). Strikingly, the inclusion of
small intestine mucosal carbohydrases has been ignored in the
vast majority of in vitro models developed to date. This issue
is particularly critical in the assessment of not only non-starchy
carbohydrates, but also in the quality of starch digestion since the
small intestinemucosal α-glucosidases have been reported to play
an important role by influencing the rate, location and extent of
glucose release which is associated with high glycaemia-related
health issues such as diabetes and other metabolic syndromes
(7). Nevertheless, recent research is addressing this caveat by
developing alternative in vitro methodology aiming to better
model the interaction of the carbohydrate with small intestine
mucosal carbohydrases as explained below.
DEVELOPMENT OF ALTERNATIVE
IN VITRO MODELS TO ASSESS
CARBOHYDRATE DIGESTIBILITY USING
MAMMALIAN SMALL INTESTINAL BRUSH
BORDER CARBOHYDRASES
TIMcarbo: A Dynamic GI Tract Model
Mimicking the in vivo Physical Processing
and Temporal Changes in Luminal
Conditions
This method has been built on the well-known TNO Gastro-
Intestinal Model (TIM), which is a multi-compartmental
dynamic model that was developed by TNO in The Netherlands
in the early 1990s in response to industrial demand to study
food products under more physiologically relevant conditions
as compared to contemporary digestion models (13, 14). The
TIMcarbo model includes an oral digestion phase by using
a model of artificial mastication with a bacterial salivary α-
amylase. After the luminal gastrointestinal digestion, which
is simulated by adding pancreatic juice containing proteases,
lipases and amylase, among other factors, the TIMcarbo mimics
the carbohydrate uptake by the epithelium. This is achieved
by dialysis of the products of digestion by a commercial rat
brush border enzyme extract complemented with a bacterial β-
galactosidase (15). The use of a microbial lactase is justified
by the fact that the rat brush border extract contains a much
lower activity than that found in humans. Finally, the in vitro
methodology is combined with an in silico kinetic modeling that
allows the prediction of glycemic response curves in humans.
This model is highly relevant to studying the digestion of
whole foods and meals where the physical condition of the
digesta changes over time, e.g., viscosity or particle size reduction
that are key determinants of the rate of carbohydrate digestion
and absorption in vivo (5, 16, 17). However, this refinedmethod is
not so suitable for screening studies or for testing the digestibility
of carbohydrates available at low amounts, which is usually a
limiting factor when the digestibility of novel carbohydrates
produced at laboratory scale needs to be assessed.
Batch in vitro Digestion Assays Using Rat
or Pig Small Intestine Mucosal
Carbohydrases
Batch models do not pretend to mimic the physical and
mechanical processes that occur in vivo. Consequently, in
this type of digestion model the products of digestion
are not removed and therefore, they do not model the
absorption process. However, this type of model is especially
suited for assessing the digestibility of isolated carbohydrates
or single foods and can provide valuable information on
mechanistic studies.
In line with the brush border enzyme digestion included
in the TIMCarbo model, the use of rat small intestinal
extract has been successfully applied for the assessment of
digestibility of several prebiotic carbohydrates. These are
non-digestible carbohydrates with the ability to selectively
modulate the composition and/or activity of the gut microbiota,
thus conferring benefit(s) upon host health (18), such as
fructooligosaccharides (19), galactooligosaccharides (20, 21), or
isomaltooligosaccharides (22).
In addition to the use of the rat intestinal extract, Lee et al.
(23) investigated the contribution of the four main individual
recombinant mucosal α-glucosidases (that is, glucoamylase,
maltase, sucrase and isomaltase) on a range of unusual α-
linked glycemic disaccharides with two glucose units. These
authors provided intriguing differences in hydrolytic properties
of the individual rat mucosal α-glucosidases to disaccharide
substrates differing in glycosidic linkages. Furthermore, they
concluded that mammalian mucosal carbohydrases must be used
in in vitro assessment of digestion of glycemic carbohydrates
instead of microbial digestive enzymes. More recently, a newly
developed in vitro digestion model, based on the use of a
commercial rat small intestinal extract under physiological
conditions of temperature and pH, was successful for evaluating
the digestibility of dietary oligosaccharides of degree of
polymerization up to four with a requirement for a minimum
of 0.5mg of carbohydrate (24). This method demonstrated its
capacity to distinguish between well-recognized digestible and
non-digestible carbohydrates; the tested digestible carbohydrates
were readily hydrolyzed whereas the oligosaccharides classified
as non-digestible were barely hydrolyzed. Remarkably, a good
correlation was found between this in vitro method and in
vivo data collected on growing (25) or neonatal (26) rats
and from aspiration of the gut content at the terminal
ileum of healthy humans (27) on galactooligosaccharides and
fructooligosaccharides digestion.
The high physiological and anatomical similarity of the
pig and human digestive tracts (28) may provide additional
advantages of using pig small intestinal material instead of
that from rats. Thus, alternative methods based on the use
of mammalian intestinal enzymes derived from pigs (6) or
weaning piglets (29) have recently been proposed. Moreover,
Tanabe et al. (30) successfully applied an improved AOAC
2009.01 method by using porcine small intestinal enzyme
instead of fungal amyloglucosidase to accurately determine non-
digestible oligosaccharides in marketed food products. In this
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TABLE 1 | Human carbohydrases involved in dietary carbohydrate digestion.
Digestive
carbohydrases
Type of enzyme Glycoside hydrolase
familya
Production organ/main site of
digestion
Glycosidic linkage
specificity
Main substratesb Main productsb
Salivary
α-amylasec
Secreted
(α-glucosidase)
13 Salivary gland/mouth Glcα(1→ 4)Glc Starch; linear
maltooligosaccharides
(n > 6)
Maltose; maltotriose;
α-dextrins
Pancreatic
α-amylasec
Secreted
(α-glucosidase)
13 Pancreas/Small intestine Glcα(1→ 4)Glc Starch; linear
maltooligosaccharides
(n > 6)
Maltose; maltotriose;
α-dextrins
Sucrase-
isomaltase
Mucosal
(α-glucosidase)
31 Small intestine (brush border
membrane)/Small intestine
Glcα(1⇔2)βFru
Glcα(1→ 4)Glc
Glcα(1→ 6)Glc
Sucrose; isomaltose;
maltose; maltotriose;
α-dextrins
Glucose; fructose
Maltase-
glucoamylase
Mucosal
(α-glucosidase)
31 Small intestine (brush border
membrane)/Small intestine
Glcα(1→ 4)Glc
Glcα(1→ 6)Glc
Linear and branched
maltooligosaccharides
(n = 2–9)
Glucose
Lactase-phlorizin
hydrolase
Mucosal
(β-glycosidase)
1 Small intestine (brush border
membrane)/Small intestine
Glcβ(1→ 4)Gal
Glcβ(1→ 4)Glc
Lactose, cellobiose,
cellotriose, cellulose
Glucose; galactose
Trehalase Mucosal
(α-glucosidase)
37 Small intestine (brush border
membrane)/Small intestine
Glcα(1⇔1)αGlc Trehalose Glucose
aAccording to CAZy database (http://www.cazy.org/) (8).
bBased on and updated from Alpers (9).
cHuman salivary and pancreatic α-amylases have 94% amino acid identity although they are encoded by different genes (10).
context, the use of small intestinal brush border membrane
vesicles conveniently isolated and purified from post-weaned
pigs has recently shown to be a reliable and straightforward
strategy to evaluate prebiotic carbohydrate digestibility, under
physiological conditions of pH, temperature and time. These
prebiotics included lactulose, different mixtures of commercial
galactooligosaccharides, and an emerging prebiotic as novel
galactooligosaccharides derived from lactulose (31). Recently,
a pioneering approach, based on the study of the trans-β-
galactosylation activity of the pig β-galactosidase embedded in
the brush border membrane vesicles, has provided significant
insights into the reaction mechanisms involved in the human
digestion of dietary carbohydrates and has informed the
development of non- or slowly-digestible carbohydrates (32).
Lastly, a novel optimized in vivo and in vitro ileal fermentation
assay, based on growing pigs as an animal model for simulating
digestion in human adults, has been reported last year (33).
Interestingly, the predicted values for ileal organic matter
digestibility (calculated on the basis of the in vivo/in vitro
ileal fermentation) were quite similar to the values measured
in vivo, warranting the potential use of appropriate, and
refined in vitro approaches using intestinal material from
growing pigs to replace in vivo studies, in relation to
ileal digestibility.
THE NEED FOR HARMONIZATION AND
STANDARDIZATION OF AN IN VITRO TEST
METHODOLOGY FOR ASSESSING
DIGESTIBILITY OF DIETARY
CARBOHYDRATES
Despite recent advances in developing in vitro methods to
assess carbohydrate digestibility, there is an obvious need
to design a standardized batch gastrointestinal digestion
method based on physiologically relevant conditions. By
considering the state-of-art, it is clear that the mucosal
disaccharidases embedded in the small intestinal brush border
membrane vesicles must be considered in addition to α-
amylases, since they play a key role in the digestion of
carbohydrates and in the subsequent uptake of monosaccharides
by the intestinal mucosa (Table 1). Additionally, the use of
mammalian digestive enzymes should be prioritized over the
use of microbial enzymes since the former better reflect the
carbohydrase activities of enzymes of the human gastrointestinal
tract. However, there are still important uncertainties that
prevent the development of a standardized methodology
in the short-term. These include (but not exclusively) the
following aspects:
(i) A large variety of enzymes from different sources have been
used to date, also differing in the assays used to determine
the enzyme activity. This clearly impairs an appropriate
characterization of the carbohydrases used as well as the
comparison of outcomes from different studies.
(ii) The regular supply of commercial pig mucosal small
intestinal enzymes is nonexistent whilst that of rats
is restricted.
(iii) The expression of mucosal carbohydrases greatly varies
among the different segments of the small intestine and is
also driven by the type of diet, as well as the host genetics,
health status and age, among other factors (34).
Possible solutions to overcome these drawbacks could be the
production of individual recombinant mucosal carbohydrases
that should provide an easier handling, as well as a more
predictable and controllable enzyme activity (23). Likewise,
estimations of the relative amount of the different mammalian
mucosal carbohydrases have been already reported (35). These
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values could be useful to establish a physiologically relevant
ratio among the different mucosal carbohydrases. Thus, the
sucrase-isomaltase complex seems to be the major mucosal
carbohydrase, followed by the maltase-glucoamylase complex,
whereas the trehalase is the less abundant enzyme (36).
Finally, a key aspect that could help to drive harmonization
and allow more effective comparison of different in vitro
digestibility conditions would be to include appropriate suits
of control digestible carbohydrates (for instance, maltose,
sucrose, starch-derived oligosaccharides, lactose, etc.) and well-
recognized non-digestible comparator carbohydrates (such as
lactulose or fructooligosaccharides).
Although there is still a considerable way to go in the
full understanding of the physical and chemical dynamics of
mammalian intestinal mucosal carbohydrases, the growing
relevance, based on their beneficial impact of human health,
of non-digestible carbohydrates emphasizes the necessity of
developing a cost-efficient, fit-for-purpose, easily implemented,
and physiologically relevant in vitro methodology which
considers all human carbohydrases involved in dietary
carbohydrate digestion.
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